01 40TAKEDA PHARMS USA
01 27790755
02 27790755*PED
03 28105626
04 28105626*PED
05 68173158
06 28173158*PED
07 38461187
08 38461187*PED
09 28722084*PED
10 38784885*PED
11 38871273
12 18871273*PED
13 39011926
14 29233103
15 39238029
16 19241910
01 40Blank
01 17Y
02 23Blank
01 52024-04-15
02 62026-01-17
03 32026-02-24
04 32026-07-17
05 22026-08-02
06 22026-09-27
07 22027-02-02
08 22027-03-27
09 32028-01-11
10 12028-07-11
11 12029-03-10
12 62030-03-17
13 22030-09-17
14 22032-03-05
Patent Expiration Date : 2030-03-17
US Patent Number : 8173158
Drug Substance Claim :
Drug Product Claim :
Application Number : 22287
Patent Use Code : U-951
Delist Requested :
Patent Use Description : TREATMENT OF HEARTBURN...
Patent Expiration Date : 2030-03-17
Patent Expiration Date : 2030-03-17
US Patent Number : 8173158
Drug Substance Claim :
Drug Product Claim :
Application Number : 22287
Patent Use Code : U-949
Delist Requested :
Patent Use Description : HEALING OF ALL GRADES ...
Patent Expiration Date : 2030-03-17
Patent Expiration Date : 2030-03-17
US Patent Number : 8173158
Drug Substance Claim :
Drug Product Claim :
Application Number : 22287
Patent Use Code : U-951
Delist Requested :
Patent Use Description : TREATMENT OF HEARTBURN...
Patent Expiration Date : 2030-03-17
Patent Expiration Date : 2030-03-17
US Patent Number : 8173158
Drug Substance Claim :
Drug Product Claim :
Application Number : 22287
Patent Use Code : U-950
Delist Requested :
Patent Use Description : MAINTAIN HEALING OF ER...
Patent Expiration Date : 2030-03-17
Patent Expiration Date : 2030-03-17
US Patent Number : 8173158
Drug Substance Claim :
Drug Product Claim :
Application Number : 22287
Patent Use Code : U-949
Delist Requested :
Patent Use Description : HEALING OF ALL GRADES ...
Patent Expiration Date : 2030-03-17
Patent Expiration Date : 2032-03-05
US Patent Number : 9233103
Drug Substance Claim :
Drug Product Claim :
Application Number : 22287
Patent Use Code : U-1805
Delist Requested :
Patent Use Description : USE OF DEXLANSOPRAZOLE...
Patent Expiration Date : 2032-03-05
Patent Expiration Date : 2032-03-05
US Patent Number : 9233103
Drug Substance Claim :
Drug Product Claim :
Application Number : 22287
Patent Use Code : U-1805
Delist Requested :
Patent Use Description : USE OF DEXLANSOPRAZOLE...
Patent Expiration Date : 2032-03-05
Patent Expiration Date : 2030-03-17
US Patent Number : 8173158
Drug Substance Claim :
Drug Product Claim :
Application Number : 22287
Patent Use Code : U-950
Delist Requested :
Patent Use Description : MAINTAIN HEALING OF ER...
Patent Expiration Date : 2030-03-17
Patent Expiration Date : 2026-02-24
US Patent Number : 9011926
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22287
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-02-24
Patent Expiration Date : 2026-08-02
US Patent Number : 7790755
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22287
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-08-02
LOOKING FOR A SUPPLIER?